title: Assessment of the Th1/Th2 paradigm in whole blood in atopy and asthma. Increased IFN-gamma-producing CD8(+) T cells in asthma.
abstract: Atopy is characterized by an immune system that is biased to T helper cell, type 2 (Th2) activation. This condition predisposes to asthma, a disease in which a Th2 activation was found in blood and lungs. However, most blood studies have considered purified cells, which might give an incomplete view of immune reactions. In this study, we assessed in whole blood cultures the Th1/Th2 paradigm in atopy and asthma. Sixty-nine subjects (31 atopic asthmatics, six nonatopic asthmatics, 13 atopic nonasthmatics, and 19 control subjects) were included in this study. Interleukin-4 (IL-4), interferon gamma (IFN-gamma), and IL-12 were assayed in stimulated whole blood culture supernatants by using a flow cytometer microsphere-based assay. Intracellular IL-4 and IFN-gamma were detected in T cells and CD8(+) T cells by flow cytometry. Atopy was characterized by a higher production of IL-4, which was correlated to total IgE levels, and by an impairment of the T-cell capacity to produce IFN-gamma. This impairment was correlated to the number of positive skin tests. In asthma, the overproduction of IL-4 was still found if atopy was present. Unexpectedly, an overproduction of IFN-gamma was found, which was related to an increased capacity of CD8(+) T cells to produce IFN-gamma. The number of IFN-gamma-producing CD8(+) T cells was related to asthma severity, to bronchial hyperresponsiveness, and to blood eosinophilia. In addition, this number was correlated to IL-12 production. These results show that in addition to the well-known Th2 inflammation in asthma, there are IFN-gamma-producing CD8(+) T cells in the blood, possibly controlled by IL-12.
authors.affiliation: UPRES 2050, Groupe de Recherche Clinique "Pathologie respiratoire et cutanée liée à l'environnement," Service de Pneumo-Allergologie, et Centre d'Investigations Cliniques, INSERM, Assistance Publique Hôpitaux de Marseille, France. amagnan@mail.ap-hm.fA
authors.forename: A O
authors.initials: AO
authors.lastname: Magnan
authors.forename: L G
authors.initials: LG
authors.lastname: Mély
authors.forename: C A
authors.initials: CA
authors.lastname: Camilla
authors.forename: M M
authors.initials: MM
authors.lastname: Badier
authors.forename: F A
authors.initials: FA
authors.lastname: Montero-Julian
authors.forename: C M
authors.initials: CM
authors.lastname: Guillot
authors.forename: B B
authors.initials: BB
authors.lastname: Casano
authors.forename: S J
authors.initials: SJ
authors.lastname: Prato
authors.forename: V
authors.initials: V
authors.lastname: Fert
authors.forename: P
authors.initials: P
authors.lastname: Bongrand
authors.forename: D
authors.initials: D
authors.lastname: Vervloet
mesh_terms: D000328:Adult; D001249:Asthma / Q000175:diagnosis / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D007371:Interferon-gamma / Q000097:blood*; D018655:Lymphocyte Count; D008297:Male; D008875:Middle Aged; D012130:Respiratory Hypersensitivity / Q000175:diagnosis / Q000276:immunology*; D018417:Th1 Cells / Q000276:immunology*; D018418:Th2 Cells / Q000276:immunology*
chemical_list: D007371:Interferon-gamma